Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

Theresa Wampler Muskardin, Priyanka Vashisht, Jessica M. Dorschner, Mark A. Jensen, Beverly S. Chrabot, Marlena Kern, Jeffrey R. Curtis, Maria I. Danila, Stacey S. Cofield, Nancy Shadick, Peter A. Nigrovic, E. William St Clair, Clifton O. Bingham, Richard Furie, William Robinson, Mark Genovese, Christopher C. Striebich, James R. O'Dell, Geoffrey M. Thiele, Larry W. MorelandMarc Levesque, S. Louis Bridges, Peter K. Gregersen, Timothy B. Niewold

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint Dive into the research topics of 'Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds